Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04231370
What this trial is testing

Lenalidomide and Sintilimab for Relapsed/Refractory NK/T-cell Lymphoma

Who this might be right for
NK/T Cell Lymphoma Nos
Beijing Tongren Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT04322383
What this trial is testing

Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant

Who this might be right for
Hairy Cell Leukemia
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Ended earlyNCT04240002
What this trial is testing

Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
Astellas Pharma Global Development, Inc. 9
Early research (Phase 1)Ended earlyNCT00313053
What this trial is testing

Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemiaAcute Lymphoid Leukemia (ALL)
Clare Twist 4
Post-approval studies (Phase 4)Not Yet RecruitingNCT06546475
What this trial is testing

A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine

Who this might be right for
Psychosis
National Taiwan University Hospital 20
Early research (Phase 1)Looking for participantsNCT06830031
What this trial is testing

Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell-lymphomaDLBCL, Nos Genetic SubtypesFollicular Lymphoma Grade 3B+3 more
Shanghai Exuma Biotechnology Ltd. 18
Early research (Phase 1)Study completedNCT03870945
What this trial is testing

Safety of MB-CART2019.1 in Lymphoma Patients (MB-CART2019.1 Lymphoma / DALY 1)

Who this might be right for
B-cell Non Hodgkin Lymphoma
Miltenyi Biomedicine GmbH 12
Not applicableLooking for participantsNCT07360977
What this trial is testing

Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)

Who this might be right for
PARKINSON DISEASE (Disorder)Multiple Sclerosis (MS) - Relapsing-remittingPediatric Patients Affected by Neuromuscolar and Degenerative Diseases
IRCCS Centro Neurolesi Bonino Pulejo 300
Not applicableStudy completedNCT06299631
What this trial is testing

Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease

Who this might be right for
Crohn's Disease
University Hospital, Montpellier 133
Testing effectiveness (Phase 2)UnknownNCT00360945
What this trial is testing

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group 87
Early research (Phase 1)Study completedNCT01830777
What this trial is testing

Brentuximab Vedotin + Re-induction Chemotherapy for AML

Who this might be right for
Acute Myelogenous Leukemia
Massachusetts General Hospital 22
Testing effectiveness (Phase 2)UnknownNCT04877275
What this trial is testing

ATG-010(Selinexor) in Combination With Chemotherapy in RRMM

Who this might be right for
Multiple Myeloma
Chunyan Sun, MD 50
Early research (Phase 1)Study completedNCT01122875
What this trial is testing

The Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genentech, Inc. 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT03846219
What this trial is testing

MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)
Immunic AG 210
Large-scale testing (Phase 3)Study completedNCT00509145
What this trial is testing

Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 1,106
Not applicableUnknownNCT05126875
What this trial is testing

Re-TREAT: Re-irradiation for Relapsed Brain Metastases

Who this might be right for
CancerBrain Metastases, Adult
Rigshospitalet, Denmark 44
Testing effectiveness (Phase 2)Study completedNCT02074657
What this trial is testing

"LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia

Who this might be right for
Relapsed/Refractory Paediatric Acute Leukaemia
Hospital Universitario La Paz 13
Testing effectiveness (Phase 2)Ended earlyNCT03093831
What this trial is testing

Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma

Who this might be right for
Lymphoma, B-Cell, Marginal Zone
National Cancer Centre, Singapore 5
Early research (Phase 1)Study completedNCT05376345
What this trial is testing

BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Shanghai Changzheng Hospital 24
Post-approval studies (Phase 4)Study completedNCT00652145
What this trial is testing

Dose Escalation and Remission (DEAR)

Who this might be right for
Ulcerative Colitis
James Lewis 119
Next Page